CTN :40906010
03 Jul, 2025
20.00 Lacs
Tender For generic medicine - bupivacaine hydochloride in dextrose injection usp each contains bupivacaine hydrochloride 5.0 mg dextrose 80.0 mg , isoflurane usp, , ketamine inj ip 50 mg/ml, , lignocaine and dextrose injection ip each mi contains lignocaine 50 mg and dextrose (monohydrate) 75 ma, , thiopentone inj ip 0.5 g, , sevoflurane, , diclofenac gastro resistant tablet ip 50 mg(enteric coate, , fentanyl citrate injection ip 2 ml, , morphine sulphate inj ip 10mg/ml, , fentanyl citrate injection 50mcg/ml, , butorphanol tartrate injection usp 1mg/ml 1ml size, , hydroxyzine tab ip 25 mg, , naloxone inj ip 0.4mg/ml, , carbamazepine tab ip 100 mg, , phenobarbitone tab ip 30 mg, , sodium valproate inj 100 mg/ml, , phenobarbitone inj ip 200mg/ml, , carbamazepine oral suspension usp 100 mg/5ml, , acyclovir oral suspension ip 400mg/5ml, , azithromycin tab 100 mg dispersible tabs (3 tab strip 10x3x3), , benzathine benzylpenicillin inj ip 12 lac units, , benzathine benzylpenicillin inj ip 6 lac units, , chloroquine phosphate inj ip 40 mg/ml, , fluconazole tablets ip 150mg, , griseofulvin tab ip 125 mg, , quinine dihydrochloride inj ip 300 mg/ml, , quinine sulphate tablets ip 300 mg (film coated), , framycetin sulphate cream 1 o/o 30gm pack, , framycetin sulphate cream 1 0/0 100 gm pack, , artemether and leumefantrine tablet (40 mg and 240 mg), , valganciclovir tablet 450 mg, , ganciclovir sodium injection 500mg (lyophilized powder for reconstitution) bleomycin injection ip 15mg (bleomycin sulphate injection 15 units), , chlorambucil tab ip 5 mg, , cyclophosphamide inj ip 500 mg, , cytarabine injection bp 500mg, daunorubicin inj ip 20 mg, , fluorouracil inj ip 250 mg/5ml, , l-asparaginase inj 10000 iu, , leucovorin calcium inj ip / calcium folinate inj ip 10 mg/m, , melphalan tab ip 5 mg, , mercaptopurine tab ip 50 mg, , alpha interferon injection interferon alpha 2 concentrated, , solution ip 3 million unit, , carboplatin injection ip 150 mg, , cisplatin inj ip 10 mg/10 ml, , ifosfamide injection ip/bp/usp 1gm, , mitomycine injection ip 10 mg//mitomycine for injection usp 10 ma, , oxaliplatin injection usp 50 mg, , procarbazine hydrochloride capsule usp 50 mg (each capsule contains procarbazine hydrochloride usp 50 mg), , bendamustine injection 100 mg, , bortezomib injection 2mg, , lomustine capsule ip 40 mg (each capsule contains lomustine ip 40 mg), , thalidomide capsule usp 100 mg (each hard gelatin capsule contains thalidomide usp 100 mg), , bevacizumab injection 400 mg, , bevacizumab injection 100 mg, , cyclophosphamide tablet ip 50 mg (each sugar coated tablet contains cyclophosphamide ip 53.5 mg equivalent to 6 thioguanine tablet usp 40 mg (each uncoated tablet contains 6. thioguanine usp 40 mg), , deferiprone cap 250 mg, , deferiprone cap 500 mg, , destermoxamine injection ip 500 mg / vial (for i.m. injand lvsc infusion), , dried human anti haemophlic fraction ip (dried factor viii, , fraction ip) 250 iu/ vial (iv use), , ethamsylate inj 250 mg/2ml (im/iv), , class="text-red-selected">vitamin k inje
ction ea
ch ml
contains menadione sodium, , bisulphite 10mg equivalent to 5.2 mg of menadione, , polygeline 3.5% solution with ele
ctrolytes for i.v. infusion, , fa
ctor ix
con
centrate (purified) ip 600 1.0.(human, ,
coagulation fa
ctor ix) anti inhibitor
coagulation
complex (human plasma protein with a fa
ctor viii inhibitor bypassing a
ctivity of 500 l ner, , dried fa
ctor viii fra
ction ip (iv use) 1000 iu/vial, , re
combinant
coagulation fa
ctor vila 1mg, , re
combinant
coagulation fa
ctor vila 2mg, , fera
crylum 1% w/v sterile solution 100 ml, , re
combinant f ix 500 iu with diluent, , 3rd generation re
combinant f viii 250 iu with diluent, , 3rd generation re
combinant f viii 1000 iu with diluent, , digoxin inj ip 0.25 mg/ml, , isosorbide dinitrate tab ip 5 mg, , lisinopril tab ip 5 mg, methyldopa tab ip 250mg film
coated, , labetalol tab ip 100mg, , lisinopril tab ip 2.5 mg, , isoprenaline inje
ction ip 2mg / ml, , urokinase inje
ction 5 la
c unit (lyophilized), , sodium nitropr